follow the right path for success, page-11

It's all very well to ride DNDN coattails on the way up but you can't have it both ways and be distanced when it has faltered. DNDN are pioneers, this sort of treatment hasn't ever had FDA approval before, there has been reiimbursement of proscribing doctor issues ( all fixed now) , there is getting doctors to accept the paradigm shift for treating prostate cancer this way and there are the issues of manufacturing quality and costs,all never been done before with a biotech. They are ironing out the issues and I think we need to be very grateful to DNDN for trail blazing and perhaps making the road a little smoother for PRR. Certainly with getting doctors used to and confident with this type of treatment.